Date: Thursday, September 4th
Time: 1:30-3:00pm
Location: Hill Auditorium, Barrows Hall | Virtual

Distinguished Lecture Series: Dr. Alon Harris
Building Bridges Across Sciences and Humanities to Preserve Vision
Description: Primary open-angle glaucoma is a leading cause of blindness, yet its underlying mechanisms remain unclear. This lecture explores the role of vascular risk factors in disease onset and progression, introducing novel imaging technologies and hemodynamic biomarkers for diagnosis and monitoring.
The presentation will highlight the integration of mathematical modeling, machine learning (ML), and artificial intelligence (AI) to enhance glaucoma risk prediction and improve diagnostic accuracy. Cutting-edge findings will demonstrate how combining AI and non-invasive imaging tools like optical coherence tomography angiography (OCTA) can revolutionize disease detection and monitoring.
The lecture will also showcase how ocular imaging, paired with AI, serves as a “window to the body,” aiding in early detection of systemic conditions such as hypertension and cardiovascular disease. Examples include the FDA-cleared “AEYE solution” for diabetic retinopathy and its innovative application to predict blood pressure from retinal images.
Finally, the session will explore the “AI revolution,” featuring pioneering smartphone apps for glaucoma diagnosis and management. These advancements illustrate the transformative potential of AI-driven tools for early detection, personalized medicine, and comprehensive ocular and systemic health monitoring.
Biography: Professor Alon Harris is a leading expert in ocular blood flow and an internationally recognized clinical researcher in glaucoma risk assessment, disease progression monitoring, ocular perfusion, imaging, population studies, and AI applications in ophthalmology. He founded a world-renowned ocular blood flow research center at Indiana University School of Medicine, focusing on glaucoma, diabetic retinopathy, macular degeneration, and ischemic optic neuropathy.
He has published over 419 peer-reviewed articles, 23 books, 72 chapters, and 662 abstracts, and co-founded the journal Modeling and Artificial Intelligence in Ophthalmology (MAIO). His Google Scholar h-index is 82.
Professor Harris has received numerous national and international awards, including the Sam Rothberg Glaucoma Award, the William and Mary Greve International Research Scholar Award, and the American Academy of Ophthalmology Achievement Award. He has secured over $7 million in research funding from the NIH, NSF, ADA, and NEI.
With extensive experience translating research into commercial solutions, he chairs XLVision and SlitLed, founded AdOM (developing imaging for dry eye disease), and has consulted for companies like Merck, Pfizer, Alcon, and Allergan. He also holds two patents on treatments to improve retinal and optic nerve blood flow.